![Stephen Mahoney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Mahoney
Vorstandsvorsitzender bei
VIRIDIAN THERAPEUTICS, INC.
Vermögen: 587 609 $ am 31.05.2026
Profil
Stephen Frank Mahoney was the founder of Kiniksa Pharmaceuticals Ltd., founded in 2015, where the title held was President & Chief Operating Officer from 2017 to 2019.
Current jobs include President, Chief Executive Officer & Director at Viridian Therapeutics, Inc. since 2023, and Director at Vesselon, Inc. Former jobs include Attorney at Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC; Chief Commercial Officer & Senior Vice President at Synageva BioPharma Corp.
from 2014 to 2015; COO, CFO, Treasurer & Chief Accounting Officer at Magenta Therapeutics, Inc. from 2020 to 2023; Chief Operating & Financial Officer at Dianthus Therapeutics, Inc. from 2020 to 2023; and Attorney at Genzyme Corp.
Education includes undergraduate studies at The Colorado College, graduate studies at Boston College Law School, and an MBA from Wallace E Carroll School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 33 349 ( 0,03 % ) | 587 609 $ | 31.05.2026 |
Aktive Positionen von Stephen Mahoney
| Unternehmen | Position | Beginn |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Vorstandsvorsitzender | 30.10.2023 |
Vesselon, Inc.
 Vesselon, Inc. Medical SpecialtiesHealth Technology Develops a portable ultrasound device for brain stroke treatment | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Stephen Mahoney
| Unternehmen | Position | Ende |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.09.2023 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Gründer | 15.11.2019 |
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 01.01.2015 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| MAGENTA THERAPEUTICS | Finanzdirektor/CFO | - |
Ausbildung von Stephen Mahoney
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Develops a portable ultrasound device for brain stroke treatment | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The Colorado College
 The Colorado College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Boston College Law School
 Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wallace E Carroll School of Management
 Wallace E Carroll School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
